Canopus BioPharma Incorporated (CBIA)

USD 0.0

(0.0%)

Market Cap (In USD)

455.07 Thousand

Revenue (In USD)

-

Net Income (In USD)

-764.7 Thousand

Avg. Volume

19.5 Million

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.0015
PE
-
EPS
-
Beta Value
0.19292374
ISIN
US1380341032
CUSIP
138034103
CIK
1404356
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Shell Companies
CEO
Mr. Patrick T. Prendergast
Employee Count
-
Website
https://www.blueheaven.cafe
Ipo Date
1999-12-31
Details
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.